Gene-Level Associations in Patients With and Without Pathogenic Germline Variants in CDKN2A and Pancreatic Cancer. Esteban Astiazaran-Symonds , Cole Graham , Jung Kim , Margaret A Tucker , Christian Ingvar , Hildur Helgadottir , Lorenza Pastorino , Remco van Doorn , Joshua N Sampson , Bin Zhu , William Bruno , Paola Queirolo , Giuseppe Fornarini , Stefania Sciallero , Brian Carter , Belynda Hicks , Amy Hutchinson , Kristine Jones , Douglas R Stewart , Stephen J Chanock , Neal D Freedman , Maria Teresa Landi , Veronica Höiom , Susana Puig , Nelleke Gruis , Xiaohong R Yang , Paola Ghiorzo , Alisa M Goldstein JCO precision oncology（2022）
摘要
These results suggest that variants in other genes likely play a role in PDAC in all patients and that PDAC in patients has a distinct etiology from PDAC in patients.
更多 查看译文
AI 理解论文
溯源树
样例
